Dr Christopher K Kaypekian, MD | |
1500 S Central Ave, Suite 126, Glendale, CA 91204-2530 | |
(818) 409-0060 | |
(818) 409-0066 |
Full Name | Dr Christopher K Kaypekian |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 23 Years |
Location | 1500 S Central Ave, Glendale, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184746380 | NPI | - | NPPES |
A86477 | Other | CA | LICENSE NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | A86477 (California) | Primary |
Entity Name | Glendale Pain Medicine Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922278381 PECOS PAC ID: 4789763855 Enrollment ID: O20080501000213 |
News Archive
In a research article published in EMBO Molecular Medicine, a group of scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.
Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of "convalescent plasma" as a treatment for COVID-19.
NT-MDT S&L (Ireland) is working in collaboration with the University of Limerick (UL) and a number of other Universities across Europe to develop an instrument, which will be capable of screening patients cells for Alzheimer's disease.
Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Christopher K Kaypekian, MD 1500 S Central Ave, Suite 126, Glendale, CA 91204-2530 Ph: (818) 409-0060 | Dr Christopher K Kaypekian, MD 1500 S Central Ave, Suite 126, Glendale, CA 91204-2530 Ph: (818) 409-0060 |
News Archive
In a research article published in EMBO Molecular Medicine, a group of scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.
Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of "convalescent plasma" as a treatment for COVID-19.
NT-MDT S&L (Ireland) is working in collaboration with the University of Limerick (UL) and a number of other Universities across Europe to develop an instrument, which will be capable of screening patients cells for Alzheimer's disease.
Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks.
› Verified 4 days ago
Dr. Laszlo Z Galffy, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1505 Wilson Ter, Suite 170, Glendale, CA 91206 Phone: 818-244-3572 Fax: 818-244-8317 |